Neutrophil-lymphocyte and platelet-lymphocyte ratios in endometrial hyperplasia
暂无分享,去创建一个
B. Çakmak | M. Nacar | Z. Ozsoy | Nurlan Aliyev | D. Koseoglu | S. Gulucu
[1] H. Aksoy,et al. Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? , 2014, Asian Pacific journal of cancer prevention : APJCP.
[2] S. Deivendran,et al. The role of inflammation in cervical cancer. , 2014, Advances in experimental medicine and biology.
[3] J. Trovik,et al. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. , 2013, Gynecologic oncology.
[4] C. Friedenreich,et al. Case–control study of inflammatory markers and the risk of endometrial cancer , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[5] J. Chang-Claude,et al. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. , 2013, American journal of epidemiology.
[6] S. Ozalp,et al. Platelet volume as a parameter for platelet activation in patients with endometrial cancer , 2013, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[7] Jia-xin Yang,et al. Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma , 2013, OncoTargets and therapy.
[8] G. Zararsiz,et al. Neutrophil–Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis , 2013, Journal of clinical laboratory analysis.
[9] Jia-xin Yang,et al. Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy. , 2013, Chinese medical journal.
[10] M. Beckmann,et al. Polymorphisms in Inflammation Pathway Genes and Endometrial Cancer Risk , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[11] Jeong-Won Lee,et al. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. , 2012, Anticancer research.
[12] D. Talwar,et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. , 2011, European journal of cancer.
[13] T. Rohan,et al. A Prospective Study of Inflammation Markers and Endometrial Cancer Risk in Postmenopausal Hormone Nonusers , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[14] L. Goldsmith,et al. Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding. , 2011, Journal of reproductive medicine.
[15] F. Clavel-Chapelon,et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case–control study , 2010, Endocrine-related cancer.
[16] P. Allavena,et al. The chemokine system in cancer biology and therapy. , 2010, Cytokine & growth factor reviews.
[17] M. Knöfler,et al. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. , 2009, Placenta.
[18] J. Metindir,et al. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma , 2008, Journal of Cancer Research and Clinical Oncology.
[19] M. Gultekin,et al. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma. , 2006, Gynecologic oncology.
[20] C. Stefanadis,et al. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. , 2006, Cytokine & growth factor reviews.
[21] R. Ness,et al. Inflammation and Endometrial Cancer: A Hypothesis , 2005, Cancer Epidemiology Biomarkers & Prevention.
[22] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[23] L. Salamonsen. Tissue injury and repair in the female human reproductive tract. , 2003, Reproduction.
[24] R. Kaaks,et al. Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .
[25] A. Zeleniuch‐Jacquotte,et al. Role of Exogenous and Endogenous Hormones in Endometrial Cancer , 2001, Annals of the New York Academy of Sciences.
[26] K. Hatch,et al. Endometrial cancer, obesity, and body fat distribution. , 1991, Cancer research.